$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc

$doc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024018706 Filed on April 26, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$695.5M	$606.6M
YoY Change	27.51%	15.39%
Cost Of Revenue	$273.8M	$243.7M
YoY Change	23.76%	9.25%
Gross Profit	$421.7M	$362.8M
YoY Change	30.08%	19.91%
Gross Profit Margin	60.63%	59.82%
Selling, General & Admin	$26.72M	$23.30M
YoY Change	3.02%	-5.08%
% of Gross Profit	6.34%	6.42%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$283.5M	$219.2M
YoY Change	43.49%	22.31%
% of Gross Profit	67.23%	60.42%
Operating Expenses	$273.8M	$243.7M
YoY Change	22.51%	9.25%
Operating Profit	$147.9M	$119.1M
YoY Change	46.87%	49.81%
Interest Expense	$74.91M	$60.91M
YoY Change	-252.65%	26.99%
% of Operating Profit	50.67%	51.14%
Other Income/Expense, Net	$126.0M	$81.77M
YoY Change	9141.06%	-0.7%
Pretax Income	$155.4M	$22.50M
YoY Change	184.57%	-83.08%
Income Tax	$2.728M	$13.70M
% Of Pretax Income	1.76%	60.88%
Net Earnings	$146.0M	$6.676M
YoY Change	182.22%	-94.39%
Net Earnings / Revenue	21.0%	1.1%
Basic Earnings Per Share	$0.21	$0.01
Diluted Earnings Per Share	$0.21	$0.01
COMMON SHARES
Basic Shares Outstanding	703.8M shares	547.2M shares
Diluted Shares Outstanding	703.3M shares	601.2M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$106.9M	$101.8M
YoY Change	2.99%	71.8%
Cash & Equivalents	$106.9M	$101.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$59.66M	$68.57M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$166.5M	$170.3M
YoY Change	5.91%	45.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.84B	$17.10B
YoY Change	26.31%	28.33%
Goodwill	$65.16M	$65.16M
YoY Change
Intangibles	$1.076B	$1.160B
YoY Change	195.26%	196.07%
Long-Term Investments	$927.2M	$930.6M
YoY Change	26.67%	30.21%
Other Assets	$52.41M	$55.40M
YoY Change	-19.4%	-4.47%
Total Long-Term Assets	$20.01B	$20.37B
YoY Change	29.57%	31.55%
TOTAL ASSETS
Total Short-Term Assets	$166.5M	$170.3M
Total Long-Term Assets	$20.01B	$20.37B
Total Assets	$20.18B	$20.54B
YoY Change	29.33%	31.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$977.2M	$1.021B
YoY Change	43.13%	48.19%
Accrued Expenses	$509.9M	$472.3M
YoY Change	149.37%	127.37%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$28.56M	$29.63M
YoY Change	-67.34%	-66.62%
Total Short-Term Liabilities	$1.516B	$1.523B
YoY Change	70.83%	69.84%
LONG-TERM LIABILITIES
Long-Term Debt	$8.574B	$8.726B
YoY Change	30.54%	35.21%
Other Long-Term Liabilities	$1.380B	$1.411B
YoY Change	35.03%	37.21%
Total Long-Term Liabilities	$9.954B	$10.14B
YoY Change	31.14%	35.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.516B	$1.523B
Total Long-Term Liabilities	$9.954B	$10.14B
Total Liabilities	$10.76B	$10.94B
YoY Change	18.66%	30.6%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$700.3M	$703.7M
YoY Change	28.02%	28.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.757B	$8.882B
YoY Change
Total Liabilities & Shareholders Equity	$20.18B	$20.54B
YoY Change	29.33%	31.66%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$146.0M	$6.676M
YoY Change	182.22%	-94.39%
Depreciation, Depletion And Amortization	$283.5M	$219.2M
YoY Change	43.49%	22.31%
Cash From Operating Activities	$316.2M	$152.6M
YoY Change	6.17%	-12.28%
INVESTING ACTIVITIES
Capital Expenditures	$122.5M	$107.1M
YoY Change	-37.12%	-50.23%
Acquisitions
YoY Change
Other Investing Activities	$310.0M	$9.269M
YoY Change	-147029.38%	-96.59%
Cash From Investing Activities	$187.5M	-$97.78M
YoY Change	-196.16%	-273.54%
FINANCING ACTIVITIES
Cash Dividend Paid		$164.2M
YoY Change		-0.47%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-501.6M	-$66.65M
YoY Change	742.98%	-72.22%
NET CHANGE
Cash From Operating Activities	316.2M	$152.6M
Cash From Investing Activities	187.5M	-$97.78M
Cash From Financing Activities	-501.6M	-$66.65M
Net Change In Cash	2.137M	-$11.87M
YoY Change	-95.06%	23.48%
FREE CASH FLOW
Cash From Operating Activities	$316.2M	$152.6M
Capital Expenditures	$122.5M	$107.1M
Free Cash Flow	$193.7M	$45.51M
YoY Change	88.04%	-210.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	138776000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	127084000	usd
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	5751000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	6163000	usd
CY2024Q1	us-gaap	Revenues Revenues	606560000	usd
CY2023Q1	us-gaap	Revenues Revenues	525678000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	60907000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47963000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	219219000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	179225000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	243729000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	223088000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23299000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24547000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	107220000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2425000	usd
CY2024Q1	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	11458000	usd
CY2023Q1	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	-2213000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	665832000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	475035000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3255000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	81578000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	78516000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	772000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	81771000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82350000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22499000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	132993000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13698000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	302000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2376000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1816000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11177000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4501000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	15555000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	6676000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	118952000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	199000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1254000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6477000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	117698000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	600898000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	546842000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	601188000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547110000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11177000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	19108000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-9477000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-64000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-64000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19172000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9413000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	30349000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	125094000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4501000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	15555000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25848000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	109539000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6876042000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	48828000	usd
CY2024Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	10994000	usd
CY2024Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	183000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19172000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2774147000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	308000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	101995000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5219000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	164414000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6995000	usd
CY2024Q1	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	263000	usd
CY2024Q1	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	10000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	136727000	usd
CY2024Q1	peak	Temporary Equity Noncontrolling Interest Increase From Business Combination TemporaryEquityNoncontrollingInterestIncreaseFromBusinessCombination	1536000	usd
CY2024Q1	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	4554000	usd
CY2024Q1	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	4554000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9544651000	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	54848000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7182598000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	105679000	usd
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	134341000	usd
CY2023Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	166000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9413000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	174000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6467000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4565000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2023Q1	peak	Proceeds From Divestitures Of Interest In Joint Venture ProceedsFromDivestituresOfInterestInJointVenture	0	usd
CY2024Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	26621000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	9640000	usd
CY2024Q1	peak	Distributions In Excess Of Earnings From Unconsolidated Joint Ventures DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures	7291000	usd
CY2023Q1	peak	Distributions In Excess Of Earnings From Unconsolidated Joint Ventures DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures	3210000	usd
CY2024Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2361000	usd
CY2023Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2650000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	165301000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	22731000	usd
CY2023Q1	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	72000	usd
CY2023Q1	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	96000	usd
CY2023Q1	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	-19967000	usd
CY2023Q1	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	-19967000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7137733000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	85902000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11177000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	219219000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	179225000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3366000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3287000	usd
CY2024Q1	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	16223000	usd
CY2023Q1	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4522000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2821000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	12093000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	747000	usd
CY2024Q1	peak	Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet	-28928000	usd
CY2023Q1	peak	Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet	-25690000	usd
CY2024Q1	peak	Income Loss From Equity Method Investments Including Discontinued Operations IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations	2376000	usd
CY2023Q1	peak	Income Loss From Equity Method Investments Including Discontinued Operations IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations	1816000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1958000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	185000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	10006000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-402000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	11458000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-2213000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3255000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	81578000	usd
CY2024Q1	peak	Gain Loss From Change Of Control GainLossFromChangeOfControl	77781000	usd
CY2023Q1	peak	Gain Loss From Change Of Control GainLossFromChangeOfControl	0	usd
CY2024Q1	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	usd
CY2023Q1	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	-529000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-819000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1698000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	2171000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	19949000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	420000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15936000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	152564000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	173921000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	0	usd
CY2023Q1	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	10219000	usd
CY2024Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	107050000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	204889000	usd
CY2024Q1	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	17517000	usd
CY2023Q1	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	22789000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	28206000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	141559000	usd
CY2024Q1	peak	Proceeds From Divestitures Of Interest In Joint Venture ProceedsFromDivestituresOfInterestInJointVenture	125662000	usd
CY2024Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	75306000	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	158381000	usd
CY2024Q1	peak	Payments To Acquire Loans Receivable And Other PaymentsToAcquireLoansReceivableAndOther	6204000	usd
CY2023Q1	peak	Payments To Acquire Loans Receivable And Other PaymentsToAcquireLoansReceivableAndOther	1918000	usd
CY2024Q1	peak	Cash Cash Equivalents And Restricted Cash Assumed As Part Of Mergers CashCashEquivalentsAndRestrictedCashAssumedAsPartOfMergers	-179215000	usd
CY2023Q1	peak	Cash Cash Equivalents And Restricted Cash Assumed As Part Of Mergers CashCashEquivalentsAndRestrictedCashAssumedAsPartOfMergers	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-97781000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	56345000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2500000000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3372255000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	343414000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	296217000	usd
CY2024Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	118619000	usd
CY2023Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	96214000	usd
CY2024Q1	peak	Initial Direct Costs Net InitialDirectCostsNet	165000000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3037000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3811861000	usd
CY2024Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	750000000	usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	399532000	usd
CY2024Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	861000	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1325000	usd
CY2024Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	5438000	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	4175000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	94000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-151000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	101995000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6467000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	164200000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	164976000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	7258000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	22803000	usd
CY2024Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	10000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	96000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-66648000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-239875000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11865000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9609000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	169023000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	126834000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	157158000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	117225000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	Business<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard & Poor’s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (“REIT”) and that, together with its consolidated entities (collectively, “Healthpeak” or the “Company”), owns, operates, and develops high-quality real estate for healthcare discovery and delivery in the United States (“U.S.”). Healthpeak® has a diverse portfolio comprised of investments in the following reportable healthcare segments: (i) outpatient medical; (ii) lab; and (iii) continuing care retirement community (“CCRC”).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s corporate headquarters are in Denver, Colorado, and it has additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts, and property management offices in several locations throughout the U.S.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2023, the Company completed its corporate reorganization (the “Reorganization”) into an umbrella partnership REIT (“UPREIT”). Substantially all of the Company’s business is conducted through Healthpeak OP, LLC (“Healthpeak OP”). The Company is the managing member of Healthpeak OP and does not have material assets or liabilities, other than through its investment in Healthpeak OP. For additional information on the UPREIT reorganization, see the Company’s Current Report on Form 8-K12B filed with the U.S. Securities and Exchange Commission (“SEC”) on February 10, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2024, the Company completed its planned merger with Physicians Realty Trust (see Note 3). Following the completion of the planned merger, shares of the Company’s common stock began trading on the New York Stock Exchange under the ticker symbol “DOC” on March 4, 2024.</span></div>
CY2024Q1	peak	Commitments Development And Redevelopment Projects And Tenant Improvements Amount Increase Decrease CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease	-2000000	usd
CY2024Q1	peak	Commitments Development And Redevelopment Projects And Tenant Improvements CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements	178000000	usd
CY2024Q1	peak	Properties Held For Sale Number PropertiesHeldForSaleNumber	0	property
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q4	peak	Initial Direct Costs Net InitialDirectCostsNet	172000000	usd
CY2024Q1	peak	Straight Line Rent Receivable Net Of Allowances StraightLineRentReceivableNetOfAllowances	321000000	usd
CY2023Q4	peak	Straight Line Rent Receivable Net Of Allowances StraightLineRentReceivableNetOfAllowances	310000000	usd
CY2024Q1	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-6260000	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-131000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	9334000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	267798000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	218450000	usd
CY2024Q1	peak	Loans And Leases Receivable Remaining Commitments LoansAndLeasesReceivableRemainingCommitments	74000000	usd
CY2024Q1	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	5000000	usd
CY2024Q1	peak	Loans Receivables Acquired LoansReceivablesAcquired	124000000	usd
CY2024Q1	peak	Number Of Loans NumberOfLoans	6	loan
CY2024Q1	peak	Loans And Leases Receivable Remaining Commitments LoansAndLeasesReceivableRemainingCommitments	74000000	usd
CY2023Q1	peak	Loans Receivable Extension Fee LoansReceivableExtensionFee	1000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	8280000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	6504000	usd
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	2088000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Sale And Reclassification To Held For Sale FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale	0	usd
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Sale And Reclassification To Held For Sale FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale	7538000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	9334000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	2830000	usd
CY2024Q1	peak	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	5600000	usd
CY2023Q4	peak	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	700000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	930559000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	782853000	usd
CY2024Q1	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	78000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1619603000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	739228000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	459157000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	425072000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1160446000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	314156000	usd
CY2024Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2024Q1	peak	Lease Up Intangible Assets Gross LeaseUpIntangibleAssetsGross	1570000000	usd
CY2023Q4	peak	Lease Up Intangible Assets Gross LeaseUpIntangibleAssetsGross	725000000	usd
CY2024Q1	peak	Above Market Lease Intangible Assets Gross AboveMarketLeaseIntangibleAssetsGross	53000000	usd
CY2023Q4	peak	Above Market Lease Intangible Assets Gross AboveMarketLeaseIntangibleAssetsGross	14000000	usd
CY2024Q1	peak	Lease Up Intangible Assets Accumulated Depreciation And Amortization LeaseUpIntangibleAssetsAccumulatedDepreciationAndAmortization	451000000	usd
CY2023Q4	peak	Lease Up Intangible Assets Accumulated Depreciation And Amortization LeaseUpIntangibleAssetsAccumulatedDepreciationAndAmortization	418000000	usd
CY2024Q1	peak	Above Market Lease Intangible Assets Accumulated Depreciation And Amortization AboveMarketLeaseIntangibleAssetsAccumulatedDepreciationAndAmortization	8000000	usd
CY2023Q4	peak	Above Market Lease Intangible Assets Accumulated Depreciation And Amortization AboveMarketLeaseIntangibleAssetsAccumulatedDepreciationAndAmortization	7000000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	374237000	usd
CY2023Q4	peak	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	228105000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	135477000	usd
CY2023Q4	peak	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	100725000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	238760000	usd
CY2023Q4	peak	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	127380000	usd
CY2024Q1	peak	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P9Y
CY2023	peak	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P7Y
CY2024Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	891000000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Lease FiniteLivedIntangibleLiabilitiesLease	852000000	usd
CY2024Q1	peak	Above Market Lease Intangibles AboveMarketLeaseIntangibles	39000000	usd
CY2024Q1	peak	Finite Lived Intangible Liabilities Acquired FiniteLivedIntangibleLiabilitiesAcquired	150000000	usd
CY2024Q1	peak	Intangible Assets Weighted Average Amortization Useful Life IntangibleAssetsWeightedAverageAmortizationUsefulLife	P6Y
CY2024Q1	peak	Intangible Liabilities Weighted Average Amortization Useful Life IntangibleLiabilitiesWeightedAverageAmortizationUsefulLife	P9Y
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	500000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	47000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	65163000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	18027000	usd
CY2024Q1	peak	Debt Costs Capitalized DebtCostsCapitalized	1000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	29626000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	803684000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1177999000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1350842000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1252815000	usd
CY2024Q1	peak	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	4300000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	8914966000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	159171000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	8755795000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5800000	shares
CY2024Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	17.11
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	100000000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	0	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	344000000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	56000000	usd
CY2024Q1	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	40353000	usd
CY2023Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	21245000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1810000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1874000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	38543000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19371000	usd
CY2024Q1	peak	Number Of Plan Participants NumberOfPlanParticipants	1	plan_participant
CY2024Q1	peak	Number Of Redeemable Noncontrolling Interest NumberOfRedeemableNoncontrollingInterest	1	interest
CY2024Q1	peak	Number Of Redeemable Noncontrolling Interest NumberOfRedeemableNoncontrollingInterest	5	interest
CY2024Q1	peak	Number Of Redeemable Noncontrolling Interest With Redemption Conditions NumberOfRedeemableNoncontrollingInterestWithRedemptionConditions	4	interest
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	11177000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	134507000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4501000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	15555000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	6676000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	118952000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	199000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1254000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6477000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	117698000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	600898000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	546842000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	181000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	268000	shares
CY2024Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits	109000	shares
CY2023Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	601188000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547110000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2024Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
CY2023Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
CY2024Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Op Units Outstanding IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnitsOutstanding	3000000	shares
CY2024Q1	peak	Number Of Facilities Owned By Unconsolidated Joint Venture NumberOfFacilitiesOwnedByUnconsolidatedJointVenture	19	property
CY2024Q1	us-gaap	Revenues Revenues	606560000	usd
CY2024Q1	peak	Interest Income Excluded From Adjusted Net Operating Income From Continuing Operations InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations	5751000	usd
CY2024Q1	peak	Real Estate Revenues From Joint Venture Attributable To Parent RealEstateRevenuesFromJointVentureAttributableToParent	29133000	usd
CY2024Q1	peak	Real Estate Revenues From Joint Venture Attributable To Noncontrolling Interest RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest	9039000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	243729000	usd
CY2024Q1	peak	Operating Expenses From Joint Venture Attributable To Parent Net OperatingExpensesFromJointVentureAttributableToParentNet	18506000	usd
CY2024Q1	peak	Operating Expenses From Joint Venture Attributable To Noncontrolling Interest OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest	2473000	usd
CY2024Q1	peak	Non Cash Adjustments To Net Operating Income From Continuing Operations NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations	-27609000	usd
CY2024Q1	peak	Adjusted Net Operating Income From Continuing Operations AdjustedNetOperatingIncomeFromContinuingOperations	333532000	usd
CY2024Q1	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	27609000	usd
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	5751000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	60907000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	219219000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23299000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	107220000	usd
CY2024Q1	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	11458000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3255000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	78516000	usd
CY2024Q1	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-10627000	usd
CY2024Q1	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-6566000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22499000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13698000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2376000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	11177000	usd
CY2023Q1	us-gaap	Revenues Revenues	525678000	usd
CY2023Q1	peak	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	137000	usd
CY2023Q1	peak	Interest Income Excluded From Adjusted Net Operating Income From Continuing Operations InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations	6163000	usd
CY2023Q1	peak	Real Estate Revenues From Joint Venture Attributable To Parent RealEstateRevenuesFromJointVentureAttributableToParent	23256000	usd
CY2023Q1	peak	Real Estate Revenues From Joint Venture Government Grant Income RealEstateRevenuesFromJointVentureGovernmentGrantIncome	228000	usd
CY2023Q1	peak	Real Estate Revenues From Joint Venture Attributable To Noncontrolling Interest RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest	9106000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	223088000	usd
CY2023Q1	peak	Operating Expenses From Joint Venture Attributable To Parent Net OperatingExpensesFromJointVentureAttributableToParentNet	16493000	usd
CY2023Q1	peak	Operating Expenses From Joint Venture Attributable To Noncontrolling Interest OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest	2635000	usd
CY2023Q1	peak	Non Cash Adjustments To Net Operating Income From Continuing Operations NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations	-4624000	usd
CY2023Q1	peak	Adjusted Net Operating Income From Continuing Operations AdjustedNetOperatingIncomeFromContinuingOperations	292460000	usd
CY2023Q1	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	4624000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	6163000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47963000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	179225000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24547000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2425000	usd
CY2023Q1	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	-2213000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	81578000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	772000	usd
CY2023Q1	peak	Interest Income Excluded From Adjusted Government Grant Income From Continuing Operations InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations	-137000	usd
CY2023Q1	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-6991000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-6471000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	132993000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	302000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1816000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	73789000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	65367000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	871000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	160000	usd
CY2024Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	15232000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	14093000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4339000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	80000	usd
CY2024Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	108797000	usd
CY2023Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	161774000	usd
CY2024Q1	peak	Noncash Or Part Noncash Retained Investments In Connection With Joint Ventures NoncashOrPartNoncashRetainedInvestmentsInConnectionWithJointVentures	69255000	usd
CY2023Q1	peak	Noncash Or Part Noncash Retained Investments In Connection With Joint Ventures NoncashOrPartNoncashRetainedInvestmentsInConnectionWithJointVentures	0	usd
CY2024Q1	peak	Non Cash Assets And Liabilities Assumed In Connection With The Mergers NonCashAssetsAndLiabilitiesAssumedInConnectionWithTheMergers	2927611000	usd
CY2023Q1	peak	Non Cash Assets And Liabilities Assumed In Connection With The Mergers NonCashAssetsAndLiabilitiesAssumedInConnectionWithTheMergers	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117635000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72032000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	51388000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	54802000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169023000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126834000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101763000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59235000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	55395000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	57990000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157158000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117225000	usd
CY2024Q1	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	64000000	usd
CY2024Q1	us-gaap	Number Of Interest Rate Derivatives Held NumberOfInterestRateDerivativesHeld	1	derivative_held
CY2024Q1	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	180000000	usd
CY2024Q1	peak	Refundable Entrance Fees Current And Noncurrent RefundableEntranceFeesCurrentAndNoncurrent	248158000	usd
CY2023Q4	peak	Refundable Entrance Fees Current And Noncurrent RefundableEntranceFeesCurrentAndNoncurrent	251874000	usd
CY2024Q1	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	108797000	usd
CY2023Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	105572000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	56411000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	59492000	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	303825000	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	240258000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	717191000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	657196000	usd
CY2024Q1	us-gaap	Severance Costs1 SeveranceCosts1	7000000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	8000000	usd
CY2024Q1	peak	Nonrefundable Entrance Fees NonrefundableEntranceFees	569412000	usd
CY2023Q4	peak	Nonrefundable Entrance Fees NonrefundableEntranceFees	562026000	usd
CY2024Q1	peak	Other Deferred Revenue OtherDeferredRevenue	354264000	usd
CY2023Q4	peak	Other Deferred Revenue OtherDeferredRevenue	343607000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	923676000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	905633000	usd
CY2024Q1	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	29000000	usd
CY2023Q1	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	29000000	usd
CY2024Q1	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	22000000	usd
CY2023Q1	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	20000000	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	15000000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	13000000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-018706-index-headers.html	Edgar Link	pending
0001628280-24-018706-index.html	Edgar Link	pending
0001628280-24-018706.txt	Edgar Link	pending
0001628280-24-018706-xbrl.zip	Edgar Link	pending
ex101003312024.htm	Edgar Link	pending
ex101103312024.htm	Edgar Link	pending
ex101203312024.htm	Edgar Link	pending
ex106.htm	Edgar Link	pending
ex106001.jpg	Edgar Link	pending
ex106002.jpg	Edgar Link	pending
ex106003.jpg	Edgar Link	pending
ex106004.jpg	Edgar Link	pending
ex106005.jpg	Edgar Link	pending
ex106006.jpg	Edgar Link	pending
ex106007.jpg	Edgar Link	pending
ex106008.jpg	Edgar Link	pending
ex106009.jpg	Edgar Link	pending
ex106010.jpg	Edgar Link	pending
ex106011.jpg	Edgar Link	pending
ex106012.jpg	Edgar Link	pending
ex106013.jpg	Edgar Link	pending
ex106014.jpg	Edgar Link	pending
ex106015.jpg	Edgar Link	pending
ex106016.jpg	Edgar Link	pending
ex106017.jpg	Edgar Link	pending
ex106018.jpg	Edgar Link	pending
ex106019.jpg	Edgar Link	pending
ex106020.jpg	Edgar Link	pending
ex106021.jpg	Edgar Link	pending
ex106022.jpg	Edgar Link	pending
ex106023.jpg	Edgar Link	pending
ex106024.jpg	Edgar Link	pending
ex106025.jpg	Edgar Link	pending
ex106026.jpg	Edgar Link	pending
ex106027.jpg	Edgar Link	pending
ex106028.jpg	Edgar Link	pending
ex106029.jpg	Edgar Link	pending
ex106030.jpg	Edgar Link	pending
ex106031.jpg	Edgar Link	pending
ex106032.jpg	Edgar Link	pending
ex106033.jpg	Edgar Link	pending
ex106034.jpg	Edgar Link	pending
ex106035.jpg	Edgar Link	pending
ex106036.jpg	Edgar Link	pending
ex106037.jpg	Edgar Link	pending
ex106038.jpg	Edgar Link	pending
ex106039.jpg	Edgar Link	pending
ex106040.jpg	Edgar Link	pending
ex106041.jpg	Edgar Link	pending
ex106042.jpg	Edgar Link	pending
ex106043.jpg	Edgar Link	pending
ex106044.jpg	Edgar Link	pending
ex106045.jpg	Edgar Link	pending
ex106046.jpg	Edgar Link	pending
ex106047.jpg	Edgar Link	pending
ex106048.jpg	Edgar Link	pending
ex106049.jpg	Edgar Link	pending
ex106050.jpg	Edgar Link	pending
ex106051.jpg	Edgar Link	pending
ex106052.jpg	Edgar Link	pending
ex106053.jpg	Edgar Link	pending
ex106054.jpg	Edgar Link	pending
ex106055.jpg	Edgar Link	pending
ex106056.jpg	Edgar Link	pending
ex106057.jpg	Edgar Link	pending
ex106058.jpg	Edgar Link	pending
ex106059.jpg	Edgar Link	pending
ex106060.jpg	Edgar Link	pending
ex106061.jpg	Edgar Link	pending
ex106062.jpg	Edgar Link	pending
ex106063.jpg	Edgar Link	pending
ex106064.jpg	Edgar Link	pending
ex106065.jpg	Edgar Link	pending
ex106066.jpg	Edgar Link	pending
ex106067.jpg	Edgar Link	pending
ex106068.jpg	Edgar Link	pending
ex106069.jpg	Edgar Link	pending
ex106070.jpg	Edgar Link	pending
ex106071.jpg	Edgar Link	pending
ex106072.jpg	Edgar Link	pending
ex106073.jpg	Edgar Link	pending
ex106074.jpg	Edgar Link	pending
ex106075.jpg	Edgar Link	pending
ex106076.jpg	Edgar Link	pending
ex106077.jpg	Edgar Link	pending
ex106078.jpg	Edgar Link	pending
ex106079.jpg	Edgar Link	pending
ex106080.jpg	Edgar Link	pending
ex106081.jpg	Edgar Link	pending
ex106082.jpg	Edgar Link	pending
ex106083.jpg	Edgar Link	pending
ex106084.jpg	Edgar Link	pending
ex106085.jpg	Edgar Link	pending
ex106086.jpg	Edgar Link	pending
ex106087.jpg	Edgar Link	pending
ex106088.jpg	Edgar Link	pending
ex106089.jpg	Edgar Link	pending
ex106090.jpg	Edgar Link	pending
ex106091.jpg	Edgar Link	pending
ex106092.jpg	Edgar Link	pending
ex106093.jpg	Edgar Link	pending
ex106094.jpg	Edgar Link	pending
ex106095.jpg	Edgar Link	pending
ex106096.jpg	Edgar Link	pending
ex106097.jpg	Edgar Link	pending
ex106098.jpg	Edgar Link	pending
ex106099.jpg	Edgar Link	pending
ex106100.jpg	Edgar Link	pending
ex106101.jpg	Edgar Link	pending
ex106102.jpg	Edgar Link	pending
ex106103.jpg	Edgar Link	pending
ex106104.jpg	Edgar Link	pending
ex106105.jpg	Edgar Link	pending
ex106106.jpg	Edgar Link	pending
ex106107.jpg	Edgar Link	pending
ex106108.jpg	Edgar Link	pending
ex106109.jpg	Edgar Link	pending
ex106110.jpg	Edgar Link	pending
ex106111.jpg	Edgar Link	pending
ex106112.jpg	Edgar Link	pending
ex106113.jpg	Edgar Link	pending
ex106114.jpg	Edgar Link	pending
ex106115.jpg	Edgar Link	pending
ex106116.jpg	Edgar Link	pending
ex106117.jpg	Edgar Link	pending
ex106118.jpg	Edgar Link	pending
ex106119.jpg	Edgar Link	pending
ex106120.jpg	Edgar Link	pending
ex106121.jpg	Edgar Link	pending
ex106122.jpg	Edgar Link	pending
ex106123.jpg	Edgar Link	pending
ex106124.jpg	Edgar Link	pending
ex106125.jpg	Edgar Link	pending
ex106126.jpg	Edgar Link	pending
ex106127.jpg	Edgar Link	pending
ex106128.jpg	Edgar Link	pending
ex106129.jpg	Edgar Link	pending
ex106130.jpg	Edgar Link	pending
ex106131.jpg	Edgar Link	pending
ex106132.jpg	Edgar Link	pending
ex106133.jpg	Edgar Link	pending
ex106134.jpg	Edgar Link	pending
ex106135.jpg	Edgar Link	pending
ex106136.jpg	Edgar Link	pending
ex106137.jpg	Edgar Link	pending
ex106138.jpg	Edgar Link	pending
ex106139.jpg	Edgar Link	pending
ex106140.jpg	Edgar Link	pending
ex106141.jpg	Edgar Link	pending
ex106142.jpg	Edgar Link	pending
ex106143.jpg	Edgar Link	pending
ex106144.jpg	Edgar Link	pending
ex106145.jpg	Edgar Link	pending
ex106146.jpg	Edgar Link	pending
ex106147.jpg	Edgar Link	pending
ex106148.jpg	Edgar Link	pending
ex10803312024.htm	Edgar Link	pending
ex10903312024.htm	Edgar Link	pending
ex22103312024.htm	Edgar Link	pending
ex31103312024.htm	Edgar Link	pending
ex31203312024.htm	Edgar Link	pending
ex32103312024.htm	Edgar Link	pending
ex32203312024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
peak-20240331.htm	Edgar Link	pending
peak-20240331.xsd	Edgar Link	pending
peak-20240331_cal.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
peak-20240331_lab.xml	Edgar Link	unprocessable
peak-20240331_pre.xml	Edgar Link	unprocessable
peak-20240331_htm.xml	Edgar Link	completed
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
peak-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc

2024 Q2 Form 10-Q Financial Statement

#000162828024018706 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOC HEALTHPEAK PROPERTIES, INC. Stock $doc

2024 Q2 Form 10-Q Financial Statement

#000162828024018706 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc